Abstract: A jet ejector arrangement, including a jet ejector with an internal nozzle having a base and a tip and, on a common longitudinal axis, an inlet for a motive fluid at the base and an outlet for the accelerated motive fluid at the tip; a hollow tube having a base and surrounding the internal nozzle, such that the base of the hollow tube surrounds the base of the nozzle, and extending downstream the tip such that the chemical components inside the hollow tube reside therein for 0.1 to 5 seconds, wherein the flow direction in the hollow tube is defined by the flow direction of the motive fluid, for mixing and reacting the motive fluid with an additional fluid feed in a reaction zone in the hollow tube, thereby providing a reacted fluid; and an opening in the wall of the hollow tube for entry of the additional fluid feed.

Abstract: A friction material has a first outermost surface and a second outermost surface spaced apart from the first outermost surface. The friction material includes a base which forms at least a portion of the first outermost surface. The base includes fibers present in an amount of from 20 to 80 weight percent, a filler present in an amount of from 20 to 80 weight percent, and a deposit which forms at least a portion of the second outermost surface and includes a friction adjusting agent. The friction material further includes a resin disposed throughout the friction material. The deposit is disposed in the friction material in a gradated pattern. At least a portion of the deposit is exposed to the environment and the second outermost surface has a surface roughness of from 2 to 11 micrometers as determined by non-contact laser measurement according to ISO 25178.

Abstract: A friction material presents a friction generating surface and a bonding surface facing opposite said friction generating surface. The friction material includes structural fibers, friction particles, polyvinyl alcohol fibers, and a resin. A method of forming the friction material is also disclosed. The method comprises the steps of: combining the structural fibers, the friction particles, and the polyvinyl alcohol fibers having an average diameter of less than about 11 ?m, an average length of less than about 4 mm, an average denier of less than about 1, to form a substrate material; impregnating the substrate material with the resin; and curing the resin to form the friction material.

Abstract: A friction material includes a base, a deposit including a friction modifier, and a resin disposed throughout the friction material. The base includes aramid fibers present in an amount of from greater than 50 weight percent to 70 weight percent, based on a total weight of the base. The base also includes a filler present in an amount from 30 weight percent to less than 50 weight percent, based on a total weight of the base. The friction material is also free of a material having a thermal degradation temperature of less than 200° C. The friction material may have a porosity of from 60% to 85% as determined using ASTM D4404-10 and a median pore size of from 0.5 ?m to 50 ?m, as determined using ASTM D4404-10.

Abstract: The present invention provides various functionalized nanodiamond particles. In particular, the present invention provides soluble complexes of nanodiamond particles and therapeutic agents, for example insoluble therapeutics, anthracycline and/or tetracycline compounds, nucleic acids, proteins, etc. The present invention also provides materials and devices for the controlled release of therapeutics, and methods for uses thereof.

Abstract: A friction material has a first outermost surface and a second outermost surface spaced apart from the first outermost surface. The friction material includes a base which forms at least a portion of the first outermost surface. The base includes fibers present in an amount of from 20 to 80 weight percent, a filler present in an amount of from 20 to 80 weight percent, and a deposit which forms at least a portion of the second outermost surface and includes a friction adjusting agent. The friction material further includes a resin disposed throughout the friction material. The deposit is disposed in the friction material in a gradated pattern. At least a portion of the deposit is exposed to the environment and the second outermost surface has a surface roughness of from 2 to 11 micrometers as determined by non-contact laser measurement according to ISO 25178.

Abstract: A friction material presents a friction generating surface and a bonding surface facing opposite said friction generating surface. The friction material includes structural fibers, friction particles, polyvinyl alcohol fibers, and a resin. A method of forming the friction material is also disclosed. The method comprises the steps of: combining the structural fibers, the friction particles, and the polyvinyl alcohol fibers having an average diameter of less than about 11 ?m, an average length of less than about 4 mm, an average denier of less than about 1, to form a substrate material; impregnating the substrate material with the resin; and curing the resin to form the friction material.

Abstract: A friction material includes a base, a deposit including a friction modifier, and a resin disposed throughout the friction material. The base includes aramid fibers present in an amount of from greater than 50 weight percent to 70 weight percent, based on a total weight of the base. The base also includes a filler present in an amount from 30 weight percent to less than 50 weight percent, based on a total weight of the base. The friction material is also free of a material having a thermal degradation temperature of less than 200° C. The friction material may have a porosity of from 60% to 85% as determined using ASTM D4404-10 and a median pore size of from 0.5 ?m to 50 ?m, as determined using ASTM D4404-10.

Abstract: The present invention provides various functionalized nanodiamond particles. In particular, the present invention provides soluble complexes of nanodiamond particles and therapeutic agents, for example insoluble therapeutics, anthracycline and/or tetracycline compounds, nucleic acids, proteins, etc. The present invention also provides materials and devices for the controlled release of therapeutics, and methods for uses thereof.

Abstract: One embodiment of the invention may include a product comprising: a friction material comprising a plurality of fibers having a fiber diameter ranging from about 1 to about 20 micrometers, the fibers comprising ceramic or mineral fibers and reinforcing fibers to add strength, the reinforcing fibers being fibrillated with a Canadian Standard Freeness greater than 300.

Abstract: A crystallization chip has a two-dimensional substrate surface with modified wetting properties convenient for the evaluation of the crystallization experiment results by optical microscope and by X-ray diffraction. A crystallization chip mount comprises a base and a support structure that is connected to the base. The support structure provides a first channel that receives a portion of the crystallization chip. A crystallization chip holder comprises a body defining at least one slot to slidably receive the crystallization chip described herein. The at least one slot extends from an upper surface to a lower surface of the body. The crystallization chip holder further includes at least one support surface for each slot. For a given slot the at least one support surface is disposed on an edge of at least two surfaces of portions of the body that define the given slot. During use, the at least one support surface supports the crystallization chip prior to, during or after the formation of crystals.

Abstract: The present invention provides various functionalized nanodiamond particles. In particular, the present invention provides soluble complexes of nanodiamond particles and therapeutic agents, for example insoluble therapeutics, anthracycline and/or tetracycline compounds, nucleic acids, proteins, etc.

Abstract: A system and apparatus for moving and packaging oriented containers through an application machine and to a container carrier wherein a plurality of containers are fed in a desired rotational position prior to a transfer turret and gripped as the transfer turret rotationally transfers the oriented container to the container carrier.

Abstract: The present invention provides materials and devices for the controlled release of therapeutics, and methods for uses thereof.

Abstract: A method, system and computer program are provided for problem determination in an enterprise computer system in a distributed environment. In the method, information is obtained regarding the enterprise applications, and high-level information is presented to a user, with one or more prompts are provided to the user for more detailed information. In response to a request from a user for more detailed information about the application, more detailed information is provided to the user. Several levels of more detailed information about applications, including information as to individual threads, is available. The method also includes the steps of receiving instructions from an administrator to establish an account for a user, associating one or more servers with the account, and providing access to the corresponding user only to the associated servers. In the method, searches may be conducted for strings and requests, and identified strings and requests may be sorted by a variety of criteria.

Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.

Abstract: This friction material has a fibrous base material and preferably is a wet friction material for use in a fluid environment. The fibers have a small diameter and a high tensile modulus resulting in flexible fibers that performs well in a high temperature, high pressure fluid environment. The fibers have a diameter ranging from 1 to 20 micrometers and a tensile modulus greater than 70 Gpa. In the preferred embodiment, the small diameter fibers are small diameter carbon fibers or small diameter mineral fibers.

Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.